Status:
COMPLETED
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period
Lead Sponsor:
Janssen Korea, Ltd., Korea
Conditions:
Gastroesophageal Reflux
Pharyngeal Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this observational study is to examine RSI (Reflux Symptom Index) and RFS (Reflux Finding Score) by treatment period before and after rabeprazole treatment in LaryngoPharyngeal Reflux D...
Detailed Description
This clinical study is a multicenter, open-label, prospective, observational study of outpatients who visit the department of otolaryngology (branch of medicine that deals with diagnosis and treatment...
Eligibility Criteria
Inclusion
- Patients who visit the department of otolaryngology with suspicious laryngopharyngeal reflux
- Patients who need rabeprazole treatment according to the doctor's discretion
- Patients who have signed an informed consent document indicating that they understand the purpose of and procedures required for the observational study and they agree to provide their information
Exclusion
- Patients who took rabeprazole within the past one month
- Patients who are hypersensitive to any of rabeprazole or benzimidazole
- Patients with severe hepatic impairment
- Pregnant or lactating women
Key Trial Info
Start Date :
September 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
1142 Patients enrolled
Trial Details
Trial ID
NCT00614536
Start Date
September 1 2007
End Date
April 1 2008
Last Update
April 28 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.